Testing effectiveness (Phase 2)Study completedNCT00000626
What this trial is testing
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Who this might be right for
HIV InfectionsHodgkin's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 27